...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: AHA 2018

Relevant to our Vascepa discussion. Twitter poll from the great Sek Kathiresan. Note, not specifically inquiring about diabetics.

Key ? from #AHA18

in a patient with established ASCVD, on high-intensity statin, and LDL 80, TG 210 what medicine would you consider adding first to lower recurrent CV event risk?

 

Share
New Message
Please login to post a reply